mPharma
PrivateLast Round
Strategic
Nov 3, 2025
Total Funding Raised
$107.23M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
mPharma is a healthcare technology company that manages medicine supply, pricing, and last-mile delivery through a network of partner pharmacies and its Mutti-branded points of care.
Sector
Healthcare & Life Sciences
Verticals
Pharma Supply Chain, Logistics Software, Telemedicine, Patient Engagement, E-commerce
Business Model
B2B2C
Customer Profile
Revenue Share, Subscription SaaS, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
mPharma Comparables
Compare mPharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Field | 85% | |
| Remedial Health | 83% | |
| DrugStoc | 82% |
mPharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Nov 3, 2025 | ||||
| Grant | Apr 30, 2025 | ||||
| Corporate Funding | Feb 9, 2024 | ||||
| Corporate Funding | Jan 1, 2024 | ||||
| Series D | Jan 5, 2022 | ||||
Series C | May 26, 2020 |
Key People
Founding team and executive leadership
mPharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Breyer Capital | Series A |
| Golden Palm Investments | Series A, Seed, Series B |
| Novastar Ventures | Series D, Series B, Series C |
| Unbound Ventures | Series B |
| 4DX Ventures | Series A, Series B |
| Oak HC/FT | Series B |
| The Skoll Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 11, 2026
Job posting indicates team has grown to over 500 members.
- Mar 28, 2026
Added Invimatic, a supply chain technology startup, as a customer.
Recent news
Latest coverage and updates
- decreases_headcount_byJul 20, 2026
mPharma Ltd decreased headcount by 150 on Dec 31st '25.
mPharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about mPharma's valuation, stock price, and market status.
Is mPharma a public or private company?
mPharma is a private company.
What is the current stock price of mPharma?
mPharma is a private company with no public stock price. No recent secondary market data is available.
How much is mPharma worth (valuation)?
Valuation information for mPharma is not publicly available.
Can I buy mPharma stock?
mPharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was mPharma's last funding round?
mPharma's most recent funding round was VC Round on January 1, 2024.
Who are the main investors in mPharma?
Key investors in mPharma include Lux Capital, NovaStar Ventures, JAM Fund, Social Capital, Unbound.
Will mPharma IPO soon?
No public IPO plans have been announced for mPharma.
How can I track mPharma secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor mPharma's secondary market activity and sign up for updates.